April 11, 2018 / 3:09 PM / 11 days ago

BRIEF-U.S. FDA Permits Marketing Of AI-Based Device To Detect Certain Diabetes-Related Eye Problems

April 11 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA PERMITS MARKETING OF FIRST MEDICAL DEVICE TO USE AI TO DETECT GREATER THAN MILD LEVEL OF THE EYE DISEASE DIABETIC RETINOPATHY IN DIABETIC ADULTS

* U.S. FDA SAYS PERMITTING MARKETING OF IDX-DR TO IDX LLC

* U.S. FDA SAYS THE DEVICE, CALLED IDX-DR, IS A SOFTWARE PROGRAM THAT USES AN AI ALGORITHM TO ANALYZE IMAGES OF THE EYE TAKEN WITH A RETINAL CAMERA Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below